Quest Health: Direct-to-Consumer Laboratory Testing

Quest Health is Quest Diagnostics’ direct-to-consumer (DTC) laboratory testing platform. It allows patients to order from 162+ tests online, visit any Quest patient service center for sample collection, and receive results through a secure portal — without a physician order. Physician oversight is provided by PWNHealth, a third-party physician network embedded in the DTC workflow. The tests themselves are identical to physician-ordered Quest tests in methodology and quality assurance.

The cardiovascular-relevant tests are priced accessibly: a basic lipid panel at $59, comprehensive metabolic panel at $49, HbA1c at $39. Advanced lipid testing — ApoB, LDL particle number, Lp(a) — is available, though pricing and panel composition vary. For patients seeking baseline cardiovascular risk data outside of a physician visit, or for those whose insurance does not cover preventive lipid testing between sick visits, DTC testing provides a practical access pathway.

The system’s greatest strength for cardiovascular patients is removing access friction. A patient who wants to know their ApoB level between annual appointments, or who wants to establish baseline values before discussing lipid management with their physician, can do so. Results arrive within days. The portal provides reference ranges and basic interpretation.

The limitation is context. A lipid panel result without a clinician conversation does not automatically translate into appropriate action. A patient who receives a high ApoB result without a clear understanding of what it means and what to do about it has information without a path forward. DTC testing is most useful when patients are engaged and have an ongoing clinical relationship into which results feed.

We rate the evidence moderate. Quest Health’s direct-to-consumer laboratory platform provides accessible, quality-assured cardiovascular risk testing — useful for patients seeking baseline data or monitoring between physician visits, with the caveat that results are most actionable in the context of clinical guidance.